CN Patent

CN114010629A — 三麦芽酚铁的剂量方案

Assigned to Medical Research Council · Expires 2022-02-08 · 4y expired

What this patent protects

本发明涉及用于治疗患有具有或不具有贫血的铁缺乏的患者的一种ST10(三麦芽酚铁)剂量方案。确切地讲，本发明涉及用30mg ST10每日两次治疗患者。

USPTO Abstract

本发明涉及用于治疗患有具有或不具有贫血的铁缺乏的患者的一种ST10(三麦芽酚铁)剂量方案。确切地讲，本发明涉及用30mg ST10每日两次治疗患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN114010629A
Jurisdiction
CN
Classification
—
Expires
2022-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Medical Research Council
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.